Vascular endothelial growth factor is a highly conserved, heparin-binding p
rotein which mediates a number of critical developmental processes in both
vertebrates and invertebrates, including angiogenesis, vasculogenesis and h
ematopoiesis. We employed an organotypic rat explant model (produced from e
mbryonic day 17 fetuses) to assess the effects of vascular endothelial grow
th factor on brain microvasculature in general and the ventral midbrain spe
cifically. Immunohistochemistry using antisera to rat endothelial cell anti
gen and laminin demonstrated a robust, dose-dependent effect of vascular en
dothelial growth factor, resulting in increased vessel neogenesis, branchin
g and lumen size by three days in vitro. This effect was blocked by additio
n of an anti-vascular endothelial growth factor antibody. At higher doses o
f vascular endothelial growth factor, the effect was attenuated, though a s
tatistically significant increase in both astrocyte, and neuronal density w
as observed using antisera to glial and neuronal markers. Tyrosine hydroxyl
ase-immunoreactive (i.e. dopaminergic) neurons, particularly, exhibited inc
reased survival in response to vascular endothelial growth factor applicati
on. Vascular endothelial growth factor had a mitogenic effect on endothelia
l cells and astrocytes, but not dopaminergic neurons, as demonstrated by th
e addition of [H-3]thymidine to the cultures 2 h after the cultures were es
tablished. Similarly, results of a radioreceptor assay indicated that speci
fic vascular endothelial growth factor binding sites were present on blood
vessels and astrocytes, and were up-regulated by exposure to vascular endot
helial growth factor.
We conclude that, in explants of the ventral mesencephalon, exogenously app
lied vascular endothelial growth factor is mitogenic for endothelial cells
and astrocytes, and promotes growth/survival of neurons in general and dopa
minergic neurons in particular. (C) 1999 IBRO. Published by Elsevier Scienc
e Ltd.